glp 1 for research GLP-1 Peptides: What Labs Need to Know GLP-1 10mg Vial (Semaglutide) |

Nausea The most common side effect is especially when starting or increasing your dose

Contact your healthcare provider promptly if you experience: Persistent dizziness lasting more than a few seconds when standing Fainting or near-fainting episodes Falls or loss of balance attributed to dizziness Chest pain, palpitations, or irregular heartbeat accompanying low blood pressure symptoms Severe or persistent nausea, vomiting, or diarrhea leading to dehydration Confusion, difficulty concentrating, or unusual fatigue Blood pressure readings consistently below 90/60 mmHg with symptoms New or worsening shortness of breath Seek emergency care (call 911) if you experience: Loss of consciousness Chest pain or pressure Severe shortness of breath Confusion or altered mental status Seizures Signs of stroke (facial drooping, arm weakness, speech difficulty) Your healthcare provider may need to adjust your GLP-1 medication dose, modify or discontinue antihypertensive medications, or investigate other potential causes of hypotension

report palpitations

While there hasnt been a published study to estimate changes in demand, we know that interest in GLP-1s likely exceeds usage

Baseline testing may include: A1C and fasting glucose to assess insulin sensitivity Lipid panel to evaluate cardiovascular risk Basic metabolic panel to review kidney function and electrolyte balance Liver function tests to identify any concerns that could affect medication use Thyroid function tests to detect hypothyroidism or other endocrine issues Additional labs as indicated by medical history or symptoms These tests help ensure that patients are receiving the right medication at the right dose

The most common side effects reported in trials include mild to moderate gastrointestinal issues: nausea, diarrhea, vomiting, and constipation